Research Article
Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
Figure 4
PPZ protects against lipopolysaccharide- (LPS-) induced bone loss in vivo. (a) Micro-CT scanning and 3D reconstruction of the entire calvaria of mice from the sham group (PBS), LPS group (LPS 5 mg/kg body weight), LPS with low-dose PPZ group (2.5 mg/kg), and LPS with high-dose PPZ group (10 mg/kg) (). (b) Quantitative analysis of bone volume/total volume (BV/TV) of calvaria (). (c, d) Number and percentage of osteolytic lesions (). Data are presented as ; , relative to control.
(a) |
(b) |
(c) |
(d) |